Lupus affects different people in different ways, and skin problems like rashes or sores are common. In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for ...

Hypertrophic LE is a rare subset of chronic cutaneous LE and represents 2% of ... of the lesions characterize this subset, although systemic involvement is rare. Hypertrophic LE has been also ...

Symptom control Use of rapidly acting agents tailored to the nature and severity of the manifestation Glucocorticoids: topical for mild cutaneous ... due to systemic lupus erythematosus and ...

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes ...

is a rare presentation occurring in people with systemic lupus erythematosus (SLE). It causes blisters on the skin and may affect the internal organs. SLE is a complex condition that can have a ...

Dermatomyositis and lupus may share symptoms in some cases. Here's what you need to know about these autoimmune conditions.

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and ...

Patients with cutaneous lupus were 1.72 times more ... 24,675 patients with systemic lupus erythematosus (SLE), 192,577 with psoriasis and 81,380 controls. Results showed that, compared with ...

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

Topical mupirocin helps reduce inflammation in lupus, offering a potential new approach for managing symptoms and improving ...

A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...

“In addition to decreasing the inflammation by decreasing lesional staphylococcus aureus, the mupirocin treatment also lowered skin monocyte levels, which are important in driving cutaneous lupus,” ...